Psykey, Inc. (OTCMKTS:CEOS) Sees Significant Growth in Short Interest

Psykey, Inc. (OTCMKTS:CEOS) was the target of a large increase in short interest during the month of November. As of November 30th, there was short interest totalling 149,000 shares, an increase of 6,108.3% from the November 15th total of 2,400 shares. Based on an average daily volume of 4,605,200 shares, the short-interest ratio is currently 0.0 days.

Psykey Price Performance

Shares of Psykey stock traded down $0.00 during trading on Wednesday, hitting $0.03. 1,336,811 shares of the stock were exchanged, compared to its average volume of 589,817. Psykey has a 12-month low of $0.01 and a 12-month high of $0.05. The firm’s 50-day moving average price is $0.02 and its 200 day moving average price is $0.02.

Psykey Company Profile

Psykey, Inc engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market.